Cargando…
Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date
Siponimod (BAF312) is a synthetic molecule belonging to the sphingosine-1-phosphate (S1P) modulator family, which has putative neuroprotective properties and well-characterized immunomodulating effects mediated by sequestration of B and T cells in secondary lymphoid organs. Compared to fingolimod (i...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679692/ https://www.ncbi.nlm.nih.gov/pubmed/29138536 http://dx.doi.org/10.2147/DDDT.S122249 |